BioSpace News Archive

Deals

Cano Health Acquires Tampa-Based Rangel Medical Center

Cano Health, LLC announced that it has acquired Rangel Medical Center.

March 13, 2018
·
1 min read
BioMidwest

Illinois Cannabis Education Expo 1st to Include Patient Education & Professional CME/CEU Platforms

Non-Profit hosts Cannabis Education w/ Professional Presenters, an Exhibition Hall, & Physician Training

March 13, 2018
·
2 min read
FDA

Cerus Announces the Fourth Biologics License Application (BLA) Approval for a U.S. Blood Center Customer

Received approval from the FDA for allowance of interstate distribution of platelets that have been pathogen-reduced with the INTERCEPT Blood System.

March 13, 2018
·
3 min read
Drug Development

New Clinical Trial Confirms DermaTherapy® Reduces Number of Pressure Injuries in Intensive Care Units

Study Published in November 2017 Issue of American Journal of Critical Care

March 13, 2018
·
4 min read
Drug Development

New Hope for ALS Patients Worldwide: Kadimastem Commences Its Clinical Trial in ALS Patients at Hadassah Medical Center After it Received Approval From the Ministry of Health

Kadimastem announced that it has received the approval of the Ministry of Health’s Supreme Committee, for conducting its phase I/IIa clinical trial in ALS patients using the unique cell therapy developed by the company.

March 13, 2018
·
4 min read
Biotech Beach

Escalier Biosciences Raises $19 Million to Develop its Topical and Systemic RORγt Therapies for Psoriasis and other Autoimmune Diseases

Escalier Biosciences BV announced the closing of a $19 million Series B financing.

March 13, 2018
·
1 min read
Drug Development

BiondVax Appoints CRO to Conduct Pivotal Clinical Efficacy Phase 3 Trial of Its Novel Universal Flu Vaccine Candidate

BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), developer of the Universal Flu Vaccine candidate M-001, announced today the signing of a Master Service Agreement (MSA) with a contract research organization (CRO) to conduct the first pivotal, clinical efficacy, Phase 3 trial of M-001.

March 13, 2018
·
4 min read
PRN Therapeutics launches nūretin®

PRN Therapeutics, the world’s leading producer of condition-specific eye care products, today announced the launch of a novel medical food formulated to reduce the risk of and slow the progression to diabetic retinopathy.

March 13, 2018
·
2 min read
Business

Phytelligence Announces JANUS Management to Consult and Catalyze Sales Discussions in Argentina

Phytelligence brings MultiPHY™ technology to South America

March 13, 2018
·
2 min read
Pharm Country

The Time is Now for More Women in Science

The Leukemia & Lymphoma Society (LLS) is shining a spotlight on the women in science who are helping to lead these advances.

March 13, 2018
·
7 min read